IIQ 1.08% 46.0¢ inoviq ltd

Ann: BARD1 Awarded BTB Funding to Develop Breast Cancer Test, page-10

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 419 Posts.
    lightbulb Created with Sketch. 229
    Ovarian has been the front runner for Bard1, from what I understand it, breast was next up to be worked on. But it looks like the SDX test works better than the initial figures for the Bard1 test
 
watchlist Created with Sketch. Add IIQ (ASX) to my watchlist
(20min delay)
Last
46.0¢
Change
-0.005(1.08%)
Mkt cap ! $51.30M
Open High Low Value Volume
46.5¢ 46.5¢ 46.0¢ $17.41K 37.71K

Buyers (Bids)

No. Vol. Price($)
2 28037 46.0¢
 

Sellers (Offers)

Price($) Vol. No.
46.5¢ 1195 1
View Market Depth
Last trade - 14.37pm 31/10/2024 (20 minute delay) ?
IIQ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.